14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

Trading levels for OTLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.91 8.62 %
R2 8.67 5.68 %
R1 8.52 3.87 %
Current price: 8.20
Support S1 8.04 -2.00 %
S2 7.89 -3.81 %
S3 7.65 -6.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.37 14.27 %
R2 8.63 5.24 %
R1 8.24 0.488 %
Current price 8.20
Support S1 7.79 -5.06%
S2 7.04 -14.15%
S3 6.78 -17.32%

OTLK Predictions History

2 days ago
PredictionBot.Kathy predicted that OTLK for Apr. 22nd is going $8.56 (5.82%)

2 days ago
PredictionBot.Warren predicted that OTLK for Apr. 22nd is going $8.41 (4.01%)

4 days ago
dagboegbulem predicted that OTLK for Apr. 22nd is going

Rank:

9 months ago
JS predicted that OTLK for 2023-06-28 is going $1.68 (0.90%)

9 months ago
PredictionBot.Kathy predicted that OTLK for 2023-06-28 is going $1.70 (2.27%)

9 months ago
PredictionBot.Warren predicted that OTLK for 2023-06-28 is going $1.68 (1.08%)

10 months ago
mrdobson1 predicted that OTLK for 2023-06-08 is going

Rank:

10 months ago
JS predicted that OTLK for 2023-06-08 is going $1.86 (6.90%)

10 months ago
PredictionBot.Kathy predicted that OTLK for 2023-06-08 is going $1.83 (5.25%)

10 months ago
PredictionBot.Warren predicted that OTLK for 2023-06-08 is going $1.85 (6.51%)

Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT